MarginsXMarginsX
Home › Markets › NONOF

Novo Nordisk A S (NONOF)

NONOF is quoted over the counter, not listed on an exchange. Novo Nordisk A S files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$41.25
+0.6% on the day
1-year return
-16.0%
Market cap
The company also trades on NYSE as NVO; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to December 31, 2025 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerNONOF, quoted over the counter
SEC CIK0000353278
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressBagsvaerd Denmark, Denmark

Warning signs

Cash runway
Cash-flow positive
26.5B DKK cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
No
20-F filed February 4, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-02-04
Cash and burn26.5B DKK cash; operating cash flow 29.8B DKK a quarter.Report 2025-12-31
Shares outstanding4,465,000,000 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte Statsautoriseret Revisionspartnerselskab, Copenhagen, DenmarkPCAOB Form AP 2026-03-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
309.1B DKK102.4B DKK119.1B DKK26.5B DKK131.0B DKK309.1B DKK20-F 2026-02-04
FY 2024
2024-12-31
290.4B DKK101.0B DKK121.0B DKK15.7B DKK102.8B DKK290.4B DKK20-F 2026-02-04
FY 2023
2023-12-31
232.3B DKK83.7B DKK108.9B DKK14.4B DKK27.0B DKK232.3B DKK20-F 2026-02-04
FY 2022
2022-12-31
177.0B DKK55.5B DKK78.9B DKK12.7B DKK25.8B DKK177.0B DKK20-F 2025-02-05
FY 2021
2021-12-31
140.8B DKK47.8B DKK55.0B DKK10.7B DKK26.6B DKK140.8B DKK20-F 2024-01-31
FY 2020
2020-12-31
126.9B DKK42.1B DKK52.0B DKK12.2B DKK10.4B DKK126.9B DKK20-F 2023-02-01
FY 2019
2019-12-31
122.0B DKK39.0B DKK46.8B DKK15.4B DKK4.5B DKK122.0B DKK20-F 2022-02-02

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in DKK.

Key SEC documents

DocumentFormFiled
Latest annual report20-F2026-02-04
Latest quarterly / interim6-K2026-11-16

Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier